Myelodysplastic Syndromes
📧 Sign up to get email alerts when something new happens for Myelodysplastic Syndromes.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2022-04-01Clinical Trial Update: CIK-Cells in Relapsing Patients With Acute Leukemia or Myelodysplastic Syndromes After SCT. [Phase 1, Phase 2]
Clinical trial update for CIK-Cells in relapsing patients with acute leukemia or myelodysplastic syndromes after stem cell transplant (Phase…
-
CLINICAL_TRIALS trial_result · 2022-03-28Clinical Trial Update: Safety and Efficiency of γδ T Cell Against Hematological Malignancies After Allo-HSCT [Phase 1, Phase 2]
This clinical trial evaluates the safety and efficacy of γδ T cell therapy after allogeneic hematopoietic stem cell transplantation in hemat…
-
CLINICAL_TRIALS trial_result · 2022-03-15Clinical Trial Update: Azacytidine + HAG Regimen vs. Azacytidine for Elderly Patients With Newly Diagnosed Myeloid Malignancy [Phase 4]
Clinical trial comparing azacitidine plus HAG regimen versus azacitidine in elderly patients with newly diagnosed myeloid malignancies; phas…
-
CLINICAL_TRIALS trial_result · 2022-03-09Clinical Trial Update: Selective Inhibitor of Nuclear Export (SINE) Selinexor (KPT-330) in Patients With Myelodysplastic Syndromes [Phase 2]
Phase 2 clinical trial of selinexor (KPT-330), a selective inhibitor of nuclear export, in patients with myelodysplastic syndromes has compl…
-
CLINICAL_TRIALS trial_result · 2022-03-02Clinical Trial Update: A Safety and Efficacy Study of Pracinostat and Azacitidine in Patients With High Risk Myelodysplastic Syndromes [Phase 2]
Phase 2 trial of pracinostat with azacitidine in high-risk myelodysplastic syndromes terminated; results posted.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2022-01-28Clinical Trial Update: Eltrombopag for the Treatment of Thrombocytopenia Due to Low- and Intermediate Risk Myelodysplastic Syndromes [Phase 2]
Phase 2 trial update evaluating eltrombopag for thrombocytopenia in patients with low- to intermediate-risk myelodysplastic syndromes (MDS).
-
CLINICAL_TRIALS trial_result · 2022-01-03Clinical Trial Update: Aza With or Without ATRA in Newly Diagnosed Unfit AML or Intermediate,High or Very High Risk MDS [Phase 2, Phase 3]
A Phase 2/Phase 3 clinical trial evaluating azacitidine with or without ATRA in newly diagnosed unfit acute myeloid leukemia or intermediate…
-
CLINICAL_TRIALS trial_result · 2021-12-21Clinical Trial Update: Calcineurin Inhibitor-Free Interventions BMT CTN 1301 for Prevention of Graft-versus-Host Disease (BMT CTN 1301) [Phase 3]
Phase 3 trial update for calcineurin inhibitor–free interventions to prevent graft-versus-host disease after transplantation has completed; …
-
CLINICAL_TRIALS trial_result · 2021-11-02Clinical Trial Update: A Dose Confirmation Study of Oral Clofarabine for Adult Patients Previously Treated for Myelodysplastic Syndromes (MDS) [Phase 2]
A Phase 2 dose-confirmation study of oral clofarabine in adults previously treated for myelodysplastic syndromes (MDS) has completed; result…
-
CLINICAL_TRIALS trial_result · 2021-10-04Clinical Trial Update: Ex-vivo Primed Memory Donor Lymphocyte Infusion to Boost Anti-viral Immunity After T-cell Depleted HSCT [Phase 1, Phase 2]
Clinical trial update on ex-vivo primed memory donor lymphocyte infusion to boost antiviral immunity after T-cell depleted hematopoietic ste…
-
CLINICAL_TRIALS trial_result · 2021-09-24Clinical Trial Update: Busulfan, Melphalan, and Fludarabine With Peri-transplant Palifermin, Followed by a T-Cell Depleted Hematopoietic Stem Cell Transplant From HLA Matched or Mismatched Related or Unrelated Donors in Patients With Advanced Myelodysplastic Syndromes (MDS) and Acute Myeloid Leukemia (AML) [Phase 2]
Phase 2 clinical trial evaluating a conditioning regimen (busulfan, melphalan, fludarabine) with peri-transplant palifermin followed by T-ce…
-
CLINICAL_TRIALS trial_result · 2021-09-22Clinical Trial Update: Azacytidine Prior to in Vivo T-cell Depleted Allo Stem Cell Transplant for Patients With Myeloid Malignancies in CR [Phase 2]
A Phase 2 clinical trial evaluated azacytidine prior to in vivo T-cell depleted allogeneic stem cell transplant in patients with myeloid mal…
-
CLINICAL_TRIALS trial_result · 2021-08-13Clinical Trial Update: Combination Chemotherapy and Donor Stem Cell Transplant in Treating Patients With Aplastic Anemia or Hematologic Cancer [Phase 2, Phase 3]
Phase 2/Phase 3 trial evaluating combination chemotherapy with donor stem cell transplant for aplastic anemia and hematologic cancers; compl…
-
CLINICAL_TRIALS trial_result · 2021-08-11Clinical Trial Update: TET2 Mutations in Myelodysplastic Syndromes and Acute Myeloid Leukemia With Azacitidine + Ascorbic Acid [Phase 2]
Phase 2 trial updating TET2 mutation targeting with azacitidine plus ascorbic acid in myelodysplastic syndromes and acute myeloid leukemia h…
-
CLINICAL_TRIALS trial_result · 2021-06-24Clinical Trial Update: Study for the Treatment of Transfusional Iron Overload in Myelodysplastic Patients [Phase 4]
Phase 4 clinical trial update for treating transfusional iron overload in patients with myelodysplastic syndromes; study completed with resu…
-
CLINICAL_TRIALS trial_result · 2021-06-16Clinical Trial Update: Oral Rigosertib in Low Risk MDS Patients Refractory to ESAs [Phase 2]
Phase 2 trial update for oral rigosertib in low-risk myelodysplastic syndromes patients refractory to ESAs.
-
CLINICAL_TRIALS trial_result · 2021-06-11Clinical Trial Update: Total Body Irradiation +/- Total Lymphoid Irradiation & Anti-Thymocyte Globulin in Non-myeloablative Hematopoietic Cell Transplantation [Phase 2]
Phase 2 trial update on Total Body Irradiation with or without Total Lymphoid Irradiation and Anti-Thymocyte Globulin in non-myeloablative h…
-
CLINICAL_TRIALS trial_result · 2021-06-09Clinical Trial Update: Sodium Stibogluconate in the MDS/AML With One of the 65 Defined p53 Mutations [Phase 2]
Phase 2 clinical trial investigating sodium stibogluconate in myelodysplastic syndromes and acute myeloid leukemia with specific p53 mutatio…
-
CLINICAL_TRIALS trial_result · 2021-03-16Clinical Trial Update: Safety and Activity of Digoxin With Decitabine in Adult AML and MDS [Phase 1, Phase 2]
Phase 1/2 trial evaluating safety and activity of digoxin in combination with decitabine for adults with acute myeloid leukemia and myelodys…
-
CLINICAL_TRIALS trial_result · 2021-03-05Clinical Trial Update: Outpatient Induction Chemotherapy in Treating Patients With Acute Myeloid Leukemia or Advanced Myelodysplastic Syndrome [NA]
Clinical trial update for outpatient induction chemotherapy in adults with Acute Myeloid Leukemia or Myelodysplastic Syndrome; trial complet…
-
CLINICAL_TRIALS trial_result · 2021-02-08Clinical Trial Update: A Study of ARRY-520 in Patients With Advanced Myeloid Leukemia [Phase 1, Phase 2]
Phase 1/2 study of ARRY-520 in advanced myeloid leukemia and myelodysplastic syndromes has completed.
-
CLINICAL_TRIALS trial_result · 2021-01-27Clinical Trial Update: Antithymocyte Globulin Compared With Supportive Care in Treating Patients With Myelodysplastic Syndrome [Phase 2]
Phase 2 trial comparing antithymocyte globulin to supportive care in myelodysplastic syndromes has completed.
-
CLINICAL_TRIALS trial_result · 2020-12-21Clinical Trial Update: Phase I/II Trial to Investigate BI 836858 in Myelodysplastic Syndromes [Phase 2]
Phase II trial update for BI 836858 in myelodysplastic syndromes; study terminated with results posted.
-
CLINICAL_TRIALS trial_result · 2020-12-10Clinical Trial Update: Bone Marrow Transplant in Treating Patients With Hematologic Cancers [Phase 2]
Phase 2 clinical trial update on bone marrow transplant for hematologic cancers (completed).
-
CLINICAL_TRIALS trial_result · 2020-11-23Clinical Trial Update: Myelodysplastic Syndromes (MDS) Event Free Survival With Iron Chelation Therapy Study [Phase 2]
Phase 2 trial update on iron chelation therapy for myelodysplastic syndromes with event-free survival data.